Amazon.com, Inc. (AMZN)
Latest news, insights and market data
Market Data
AI Insights
Amazon received an FDA warning for unapproved listings of STI treatments on its platform, which could lead to product seizures if not addressed. This regulatory issue highlights the challenges Amazon faces in managing marketplace compliance and could impact its reputation. The upcoming Q3 earnings release on October 29 will be crucial for assessing investor sentiment.
Latest News
| Title | Published |
|---|---|
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test? Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test? | about 1 hour ago |
3 Cash Flow Stocks To Watch In October 2026 3 Cash Flow Stocks To Watch In October 2026 | about 6 hours ago |
AI Investment Impact Understated In U.S. 'It' Market: Texas Reveals Texas leads the AI infrastructure boom with data centers and chips boosting GDP and jobs. Check out this look at the tech sector and its prospects. | about 10 hours ago |
Amazon.com (AMZN) Received An FDA Warning Over Unapproved STI Drug Listings Amazon.com (AMZN) Received An FDA Warning Over Unapproved STI Drug Listings | about 17 hours ago |
Amazon.com (AMZN) Received An FDA Warning Over Unapproved STI Drug Listings On 15 October 2026, Amazon.com (NasdaqGS:AMZN) received an FDA warning letter over unapproved drug products for sexually transmitted infections. The FDA cited multiple marketplace listings that it says were marketed as treatments or cures without required drug approvals. Regulators warned that continued sale of these items could trigger product seizures or injunctions if Amazon does not correct the issues. The FDA warning over unapproved STI treatments is important, but should sit alongside... | about 17 hours ago |
Should you Buy Amazon Stock Before October 29? History Has a Clear Answer. Amazon releases its third-quarter 2026 earnings on that day. | about 21 hours ago |
Discount grocery chain closing all stores as bargain grocers struggle Discount grocery chain closing all stores as bargain grocers struggle | about 22 hours ago |
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test?
Amazon (AMZN) Is A Proven Capital Allocator. But Can it Pass Its $220 Billion Test?
3 Cash Flow Stocks To Watch In October 2026
3 Cash Flow Stocks To Watch In October 2026
AI Investment Impact Understated In U.S. 'It' Market: Texas Reveals
Texas leads the AI infrastructure boom with data centers and chips boosting GDP and jobs. Check out this look at the tech sector and its prospects.
Amazon.com (AMZN) Received An FDA Warning Over Unapproved STI Drug Listings
Amazon.com (AMZN) Received An FDA Warning Over Unapproved STI Drug Listings
Amazon.com (AMZN) Received An FDA Warning Over Unapproved STI Drug Listings
On 15 October 2026, Amazon.com (NasdaqGS:AMZN) received an FDA warning letter over unapproved drug products for sexually transmitted infections. The FDA cited multiple marketplace listings that it says were marketed as treatments or cures without required drug approvals. Regulators warned that continued sale of these items could trigger product seizures or injunctions if Amazon does not correct the issues. The FDA warning over unapproved STI treatments is important, but should sit alongside...
Should you Buy Amazon Stock Before October 29? History Has a Clear Answer.
Amazon releases its third-quarter 2026 earnings on that day.
Discount grocery chain closing all stores as bargain grocers struggle
Discount grocery chain closing all stores as bargain grocers struggle